(Total Views: 491)
Posted On: 12/09/2021 9:33:32 AM
Post# of 154850
If it is basically the same protocol in the US as we have now in brazil, can Cytodyn combine the data of both trials?
What if US FDA wants to change e.g. 1 secondary endpoint (just to screw us around), can we still put the results of both trials together and get a higher "n"?
What if US FDA wants to change e.g. 1 secondary endpoint (just to screw us around), can we still put the results of both trials together and get a higher "n"?
(0)
(0)
